End-of-day quote
Other stock markets
|
||
- USD | - |
|
2014 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
2014 | Roche : rules out mega deals, open to smaller ones - paper | RE |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Chief Tech/Sci/R&D Officer | 69 | 02-03-31 | |
Carla Fiankan
LAW | General Counsel | - | 11-07-31 |
1st Jan change | Capi. | |
---|---|---|
+17.72% | 44.87B | |
-10.33% | 37.8B | |
+41.22% | 37.61B | |
+29.36% | 31.32B | |
-8.44% | 27.4B | |
+12.45% | 26.32B | |
+44.19% | 14.07B | |
+31.93% | 12.5B | |
-7.67% | 11.23B |
- Stock Market
- Equities
- Stock